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Alzheimer’s disease is commonly regarded as a loss of memory for past events. However, patients with Alzheimer’s disease
seem not only to forget events but also to express false confidence in remembering events that have never happened. How and
why false recognition occurs in such patients is currently unknown, and treatments targeting this specific mnemonic abnormality
have not been attempted. Here, we used a modified object recognition paradigm to show that the tgCRND8 mouse—which
overexpresses amyloid b and develops amyloid plaques similar to those in the brains of patients with Alzheimer’s disease—
exhibits false recognition. Furthermore, we found that false recognition did not occur when tgCRND8 mice were kept in a dark,
quiet chamber during the delay, paralleling previous findings in patients with mild cognitive impairment, which is often con-
sidered to be prodromal Alzheimer’s disease. Additionally, false recognition did not occur when mice were treated with the
partial N-methyl-D-aspartic acid receptor antagonist memantine. In a subsequent experiment, we found abnormally enhanced
N-methyl-D-aspartic acid receptor-dependent long-term depression in these mice, which could be normalized by treatment with
memantine. We suggest that Alzheimer’s disease typical amyloid b pathology leads to aberrant synaptic plasticity, thereby
making memory representations more susceptible to interfering sensory input, thus increasing the likelihood of false recogni-
tion. Parallels between these findings and those from the literature on Alzheimer’s disease and mild cognitive impairment
suggest a mechanism underlying false recognition in these patients. The false recognition phenomenon may provide a novel
paradigm for the discovery of potential therapies to treat the mnemonic dysfunction characteristic of this disease.
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Introduction
Alzheimer’s disease is a progressive, neurodegenerative disease
that is associated with an impairment in memory. While memory
distortions are usually thought to be due to a failure to encode or
recall specific events, a number of studies have shown that pa-
tients with Alzheimer’s disease or its prodromal condition, mild
cognitive impairment, also express false memories for events
they have never experienced (Hart et al., 1985; Budson et al.,
2000; Gold et al., 2007; Hildebrandt et al., 2009; Plancher
et al., 2009; Abe et al., 2011). How and why false memories
occur in such patients is currently unknown, and the majority of
clinical trials do not consider this specific mnemonic abnormality
when assessing potential new treatments (Budson et al., 2002).
In this study, we first investigated whether elevated amyloid
b levels can lead to false recognition. We tested a mouse model
of Alzheimer’s disease-typical amyloid b pathology—the tgCRND8
mouse, which overexpresses amyloid precursor protein with the
Swedish and Indiana mutations and develops amyloid plaques
like those in the brains of patients with Alzheimer’s disease
(Chishti et al., 2001)—on a modified version of the spontaneous
object recognition paradigm (McTighe et al., 2010) (Fig. 1). In this
‘decoupled’ object recognition procedure, animals are allowed to
explore an object during a study phase, and then, after a short
delay, are allowed to explore the studied object or a novel object
in a test phase. Normal rats and mice spend more time exploring a
novel object than a repeated object. Crucially, this version of the
recognition memory test allowed us to distinguish between false
recognition, which is reflected in the reduced exploration of a
novel object relative to controls (they erroneously think they
have seen it before), and the loss or inaccessibility of information
from memory, reflected in the enhanced exploration of the
already-studied object relative to controls (they erroneously think
they have not seen it before). The behaviour of the tgCRND8
mice clearly conformed to the former, and not the latter pattern,
indicating false recognition.
To test our hypothesis that this false recognition effect was due
to enhanced encoding of interfering information, we tested per-
formance of the mice under conditions of sensory restriction
during the delay. It has previously been shown that a period in
a dark quiet room, i.e. sensory restriction, enhanced recognition in
participants with mild cognitive impairment, thought to be a pro-
dromal stage of Alzheimer’s disease (Della Sala et al., 2005). This
treatment restored performance of tgCRND8 mice to normal
levels, indicating that interference is a likely mechanism underlying
the false recognition effect. In a subsequent experiment, we
Figure 1 A modified version of the spontaneous object recognition task, in which exploration of the repeated and novel object is
decoupled. All animals received a study exposure to two copies of object A for 5 min. After a delay of 1 h, animals received a test exposure
of 5 min to either two copies of a novel object, object B (novel condition) or to two new copies of object A (repeated condition). During the
delay, animals were put either (A) into an individual holding cage (standard condition) or (B) into a visually restricted environment
(reduced interference condition). (C) A second cohort of animals were treated with the NMDA receptor antagonist memantine
immediately after the study phase and then kept under standard conditions during the delay.
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treated mice with the partial N-methyl-D-aspartic acid (NMDA)
receptor antagonist memantine during the delay. Interestingly,
this treatment also restored performance of tgCRND8 mice to
normal levels. Finally, long-term depression of synaptic transmis-
sion in the perirhinal cortex is thought to be a critical mechanism
underlying recognition memory (Cho et al., 2000; Griffiths et al.,
2008), and amyloid b leads to abnormally high levels of NMDA
receptor long-term depression (Kim et al., 2001; Cheng et al.,
2009). We therefore hypothesized that aberrant synaptic plasticity
might comprise at least part of the mechanism underlying false
recognition in the tgCRND8 mice. Indeed, we found enhanced
NMDA receptor-dependent long-term depression in slices taken
from these mice which, like the false recognition in the mice,
could be normalized by treatment with memantine. Taken to-
gether, the behavioural and electrophysiological data support the
suggestion that tgCRND8 mice demonstrate false recognition as a
result of enhanced encoding of interfering information, and that
this enhanced susceptibility to interference may be due to altered
synaptic plasticity.
Materials and methods
Animals
Heterozygous tgCRND8 mice (Chishti et al., 2001) and wild-type lit-
termates were received from Michael Coleman at the Babraham
Institute, Cambridge and housed under standard conditions in
groups of two or three on a 12 h light/12 h dark cycle (lights on
07:00). All behavioural testing was conducted during the light phase
of the cycle. Food and water were available ad libitum throughout the
experiment.
Animals of all cohorts were 8–10 weeks old at the onset of testing,
correlating with the occurrence of the first amyloid b plaque deposits
in the cortex (Adalbert et al., 2009). All experimentation was con-
ducted in accordance with the UK Animals (Scientific Procedures)
Act, 1986.
Object recognition task
Object recognition was conducted as previously described for rats
(McTighe et al., 2010), using a Y-shaped apparatus adapted for
mice (Bartko et al., 2007b) (Fig. 1). The Y-apparatus had high, homo-
geneous white walls constructed from Perspex to prevent the mouse
from looking out into the room, thereby maximizing attention to the
stimuli. All walls were 30 cm high, and each arm was 16 cm in length
and 8 cm wide. A lamp illuminated the apparatus, and a white shelf,
50 cm from the top of the apparatus, created a ceiling on which a
video camera was mounted to record trials. One arm was used as the
start arm, and the other two arms were used to display the objects
(randomly shaped junk objects, dimensions 10  4  4 cm). All mice
were habituated to the apparatus in two consecutive daily sessions in
which they were placed in the start arm and left to explore the empty
Y-apparatus for 5 min.
The following task sessions were separated by a minimum of 48 h,
which the animals spent under normal holding conditions in their
home cages. Task sessions were performed in the morning (light
cycle, 09:00–14:00) and consisted of a study phase and a test
phase. In the study phase, two identical ‘object A’s’ were placed at
the end of each arm. The animal was placed in the start arm and left
to explore the objects for 5 min. After a delay of 1 h, which the animal
spent either in its home cage (high interference) or in a dark, quiet
chamber (low interference; Fig. 1), the procedure was repeated (test
phase). However, in the test phase, animals were presented either with
two new copies of object A, or two copies of a novel object B. After
the test phase, animals were returned to the home cage until the onset
of the next task session (at least 48 h later). Each animal received two
test sessions for each trial type (repeated versus novel object), and the
order of trial types as well as the designated study and novel objects
for each pair (A! B versus B!A) were counterbalanced within and
across groups.
The time spent exploring objects was assessed from video recordings
of the study and test phases. Exploratory bouts were scored using a
personal computer running a custom made program written in Visual
Basic 6.0 (Microsoft). Times when an animal climbed or sat on an
object were not counted. For the test phase, a discrimination score
was calculated by dividing the exploration of the novel or repeated
objects by the exploration time of the sample object. Therefore, a
score of 1 corresponded to equal exploration of study and test
object (no discrimination). The mean discrimination score across the
two test sessions per condition was calculated for each animal.
Group mean discrimination scores were compared by repeated
measures ANOVA with genotype as between-subjects factor, and
interference level or drug treatment (sensory restriction/memantine
versus standard condition) and trial type (novel versus repeated
object) as within subject factors. Where appropriate, simple main ef-
fects analysis was performed for individual factors, adjusted after Sidak
for multiple comparisons using SPSS 17 (SPSS Inc.; significance level
P5 0.05).
Drug administration
Memantine (5 mg/kg) or vehicle (physiological saline) was systemic-
ally administered (intraperitoneal injection, counterbalanced across
animals in a group and across conditions) immediately following the
study phase, 15 min before the study phase or 15 min before the
choice phase. The time of application was guided by previous studies
reporting significant behavioural effects of acute memantine 15 min
after intraperitoneal application in mice (Costa et al., 2008). To
avoid accumulation effects, each dosing day was followed by three
washout days.
Neuritic plaque histology
Mice (tgCRND8 and wild-type) at 2–3 months of age were sacri-
ficed by overdose of sodium pentobarbital (Dolethal; Vetoquinol
UK Ltd.) administered by intraperitoneal injection. The mice were
then perfused transcardially with phosphate-buffered saline (pH 7.4)
followed by 10% neutral-buffered formalin (pH 7.4). Following per-
fusion, brains were removed and post-fixed in 10% neutral-buffered
formalin followed by cryoprotection in 20% (w/v) sucrose in
phosphate-buffered saline. The tissue was then embedded in Jung
Tissue Freezing Medium (Leica Microsystems Nussloch GmbH) and
stored at 80C until sectioning. Before sectioning, the tissue was
transferred to 20C to equilibrate for 24 h. Following equilibration,
sectioning at 30 mm was performed using a microtome. Sections were
collected and stored in phosphate-buffered saline until immunohisto-
chemical processing.
The immunohistochemical protocol used was based on previously
published methods (Ly et al., 2011). Briefly, sections were immersed
in 0.5% hydrogen peroxide in 0.3% Triton X-100 in phosphate-
buffered saline (PBST) for 30 min at room temperature, washed for
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10 min in PBST three times and then blocked for 60 min at room tem-
perature in 5% (w/v) non-fat skimmed milk in PBST (PBST-M).
Sections were then incubated with 1:2000 biotinylated mouse anti-b
amyloid 17–24 (4G8) primary antibody (Covance Inc.) in PBST-M
overnight at 4C. Following incubation, sections were washed in
PBST three times for 10 min and then incubated with freshly prepared
ABC solution (Vector Laboratories Ltd.) for 30 min. Three further
10 min washes in PBST were performed before the sections were incu-
bated in freshly prepared 3,30-diaminobenzidene solution (Vector
Laboratories Ltd.) until colour development. Sections were then
washed in PBST for 10 min a further three times before mounting
on Superfrost Plus microscope slides (Gerhard Menzel GmbH).
Slides were allowed to dry overnight before immersion in cresyl
violet solution for 60 min at 40C. Slides were then briefly differen-
tiated in 70% ethanol and dehydrated through an ethanol series
before xylene clearing and mounting with Histomount (National
Diagnostics). Slides were imaged using a densitometry imaging
system (Interfocus Imaging Ltd.) and perirhinal cortex was identified
by comparison to the Allen Institute for Brain Science Mouse Brain
Reference Atlas (P56 coronal series; Allen Mouse Brain Atlas 2009;
Lein et al., 2007).
Electrophysiology
Perirhinal cortex slices were prepared from tgCRND8 and wild-type
mice. Experiments were carried out in accordance with the UK
Animals Scientific Procedures Act of 1986. Animals were sacrificed
by dislocation of the neck and then decapitated. The brain was rapidly
removed and placed in ice-cold artificial CSF containing (in mM):
124 NaCl, 3 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 CaCl2, 1 MgSO4,
10 D-glucose (bubbled with 95% O2/5% CO2). A mid-sagittal section
of the brain was made, with tissue removed from both rostral and
caudal sections of the section, at 45 alignment to the dorsoventral
axis. The sections were then fixed, by the caudal end, to a vibrotome
stage (VT1000S, Leica). Slices (400 mm) were submerged in artificial
CSF (20–25C) and incubated for 1 h. As required, single slices were
placed into a submerged recording chamber (27–29C; flow rate
3 ml/min). Extracellular field potentials were recorded in the layer
II/III of area 35 of the perirhinal cortex using glass electrodes contain-
ing NaCl (3 M). Stimulating electrodes were placed on either side of
temporal and entorhinal input of the perirhinal cortex (Cho et al.,
2000). Stimuli (constant voltage) were delivered alternately to the
two electrodes (each electrode 0.016 Hz). Long-term depression was
evoked by low frequency stimulation (1 Hz, 900 pulses). The peak
amplitude of the evoked field potential responses was measured and
expressed relative to the normalized preconditioning baseline. Data
were recorded using an Axopatch 700B amplifier (Axon
Instruments). Data were monitored and analysed online and re-analy-
zed offline using the WinLTP software (http://www.ltp-program.com).
Results
In agreement with previous reports of abundant amyloid b path-
ology in the cortex of 2- to 3-month-old tgCRND8 mice (Adalbert
et al., 2009), immunohistochemical analysis of 2- to 3-month-old
tgCRND8 tissue showed plaque-like amyloid b deposits in the
perirhinal cortex (Fig. 2), a medial temporal lobe structure neces-
sary for object recognition memory (Meunier et al., 1993; Mumby
and Pinel, 1994; Winters et al., 2008). Consistent with previously
described recognition memory deficits in mouse models of
Alzheimer’s disease (Francis et al., 2012; Greco et al., 2010),
tgCRND8 mice did not discriminate between novel and repeated
objects and explored both types of objects to a similar degree
(Fig. 3A and B; no effect of trial type: F51). Crucially, however,
we found that the memory impairment was not due to these
animals treating the repeated object as novel [i.e. a loss of the
memory trace that would be reflected in enhanced exploration of
the studied object (Fig. 3B); no main effect of genotype on re-
peated object exploration, F5 1], but rather was due to these
animals treating the novel object as familiar [i.e. false recognition
as reflected in the reduced exploration of the novel object; main
effect of genotype on novel object exploration: F(1, 16) = 5.1;
P50.05]. Thus, tgCRND8 mice paradoxically express recognition
of objects they have never encountered, suggesting that false rec-
ognition is a direct consequence of Alzheimer’s disease typical
amyloid b pathology. Importantly, exploration times of objects
during the study phases were not significantly different between
genotypes (Fig. 3A). Since the intervals between subsequent study
phases were longer than the usual object memory retention span
of a mouse (524 h; Sik et al., 2003), this finding suggests that
reduced exploration of the novel objects during the test phase was
not related to a general, altered response to novelty regardless of
mnemonic demands.
In the next set of experiments, we aimed to investigate
whether, as we found in a previous lesion experiment (McTighe
et al., 2010), false recognition might be due to increased interfer-
ence during the delay. In order to reduce sensory interference, we
placed the animals in a dark, empty, quiet chamber during the
interval between study and test phase (Fig. 1B). Strikingly,
tgCRND8 mice kept under sensory restriction no longer falsely
recognized novel objects, and like wild-type animals spent more
time exploring the novel object than the studied object [Fig. 3A
and C; effect of trial type: F(1, 16) = 9.9; P50.01; effect of visual
interference on novel exploration: F(1,16) = 8.8; P50.01]. They
performed identically to wild-type mice [no simple main effect of
genotype: F(1, 16) = 1.8; P40.1], who were unaffected by sen-
sory restriction (no simple main effect of interference level: F51).
Thus, preventing visual and other sensory input after the study
phase completely abolished false recognition, which suggests that
amyloid b pathology can heighten susceptibility to interference.
It is thought that a principle mechanism underlying the encod-
ing of object information is NMDA receptor-dependent long-term
depression (Cho et al., 2000; Griffiths et al., 2008). As aberrant
long-term depression has been observed previously in rodent
models of Alzheimer’s disease (Kim et al., 2001; Cheng et al.,
2009), we hypothesized that aberrant encoding of interfering in-
formation in these mice might be due to aberrant long-term de-
pression. To test this idea, we next applied the low-affinity
NMDA-type glutamate receptor antagonist memantine during
the delay, immediately after the study phase (Fig. 1C). The
time-course of memantine application in this and the following
experiments was guided by previous studies reporting signifi-
cant behavioural effects of acute memantine 15 min after
intraperitoneal application in mice (Costa et al., 2008). Although
the half-life of memantine in rodents is short (3–5 h; Parsons et al.,
1999), each dosing day was followed by three washout days
where the animals remained in their home cage.
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In contrast to saline-treated tgCRND8 mice (no effect of trial
type: F51), memantine-treated tgCRND8 mice no longer treated
novel objects as familiar and spent more time exploring the novel
object than the previously studied object [Fig. 4A; effect of mem-
antine on novel object exploration: F(1, 18) = 6.6; P50.05, main
effect of trial type: F(1, 18) = 10.8; P50.01]. Their performance
was indistinguishable from wild-type performance (no effect of
genotype, F51), which was unaffected by the drug (no effect
of memantine: F52.6; P4 0.1).
However, it is possible that the action of memantine could have
persisted throughout the retrieval phase and thus, rather than pre-
venting enhanced plasticity during the delay, may have somehow
Figure 2 Amyloid b deposits in and around the tgCRND8 perirhinal cortex at 2–3 months of age. (A) Diagrammatic representation of
perirhinal cortex (PERI) and surrounding brain regions. Image adapted from: Allen Institute for Brain Science Mouse Reference Atlas (P56
coronal series) (Allen Mouse Brain Atlas; Lein et al., 2007). (B) Immunohistochemical processing of wild-type tissue using 4G8
anti-amyloid 17–24 antibody reveals no evidence of plaque pathology. (C) Plaques present in the perirhinal cortex of the tgCRND8 mouse
as detected by the 4G8 antibody. Arrowhead indicates perirhinal cortex region.
Figure 3 False recognition in tgCRND8 mice. (A) Exploration times during the study phase did not differ between genotypes or levels of
visual interference, suggesting the absence of obvious genotype-related behavioural differences that might have influenced the initial
object-encoding phase. (B) Under standard conditions, tgCRND8 mice (n = 7) did not discriminate between novel and repeated objects in
the test phase and falsely treated novel objects as familiar. (C) If interfering visual input was minimized during the delay, performance of
tgCRND8 mice was indistinguishable from performance of wild-type mice (n = 11). Object preference was calculated by dividing test
object exploration by study object exploration time. Therefore, a score of 1 corresponded to equal exploration in the study and test phases,
whereas a score of 0.5 corresponded to the mouse exploring half as much in the test phase as it had in the study phase [group
mean + SEM, repeated measures ANOVA, genotype  interference level  trial type: F(1,16) = 4.3, P50.05, simple main effects:
**P50.01, *P50.05]. ns = not significant.
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Figure 4 Effect of memantine. (A) Memantine applied immediately after the study phase rescued false recognition in tgCRND8 mice
without affecting wild-type performance [wild-type: n = 9, tgCRND8: n = 11, repeated measures ANOVA, genotype  memantine  trial
type: F(1,18) = 4.7, P50.05; simple main effects: ***P50.005, **P50.01, *P5 0.05]. (B) Memantine applied only before to the test
phase did not enhance tgCRND8 performance [same animals as in A, repeated measures ANOVA, genotype  trial type: F(1,18) = 3.7,
P = 0.05; simple main effects: ***P50.005, **P5 0.01, *P50.05]. (C) Memantine injected before the study phase also rescued
tgCRND8 performance, and had no effect on object discrimination performance of wild-type mice [new age matched cohort, wild-type:
n = 11, tgCRND8: n = 10; repeated measures ANOVA, genotype  memantine  trial type: F(1,19) = 3.8, P = 0.05; simple main effects:
***P50.005, **P5 0.01, *P50.05]. Memantine had no effect on exploration times of the study phase (left, repeated measures
ANOVA, all F51). All data are presented as mean + SEM. ns = not significant.
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facilitated retrieval operations. To test this possibility, we next in-
jected the drug prior to the test phase. Pretest phase
memantine did not affect the recognition memory performance
of tgCRND8 or control mice (Fig. 4B; no effect of memantine or
interactions involving memantine: all F51.4; P40.1). Neither
memantine-treated nor saline-treated tgCRND8 mice discrimi-
nated between novel and repeated objects (no effect of trial
type or interactions involving trial type, all F51), and spent sig-
nificantly less time exploring the novel object than wild-type con-
trols. Thus, the reduction of false recognition by post-study phase
memantine is not due to facilitated memory retrieval during the
test phase.
Finally, we addressed whether memantine treatment not only
prevented erroneous memories in tgCRND8 mice, but would also
affect the normal formation of representations of salient novel
objects. We administered memantine prior to the study phase,
which had no effect on object exploration times during the
study phase in either genotype (Fig. 4C). Prestudy memantine
treatment also had no effect on object recognition in wild-type
mice [Fig. 4C; no effect of memantine: F51; effect of trial type:
F(1,19) = 4.8; P50.05]. In tgCRND8 mice, the effect of prestudy
memantine was comparable to the effects of memantine admin-
istered after the study phase [Fig. 4A and C, simple main effect of
memantine on novel object exploration: F(1,19) = 5.2; P50.05;
simple main effect of trial type: F(1,19) = 8.6; P50.01].
Therefore, memantine did not abolish the encoding of represen-
tations of salient novel objects either in wild-type or in tgCRND8
mice. The implication is that whereas memantine can block the
encoding of interfering incidental familiar object information, it is
insufficient to block encoding of a salient novel object.
These behavioural–pharmacological findings with memantine
are consistent with the idea that amyloid b pathology alters
NMDA receptor-dependent synaptic plasticity such as long-term
depression and that this altered synaptic plasticity leads to aber-
rant encoding of interfering information leading to false recogni-
tion. To test the plausibility of this mechanism at the cellular level,
we made extracellular field recordings in perirhinal cortex slices
from 10-week-old wild-type and tgCRND8 mice. We delivered a
low-frequency long-term depression–induction protocol, which is
known to induce reliable, NMDAR-dependent long-term depres-
sion in juvenile mice, but commonly fails to induce long-term de-
pression in adult animals (low frequency stimulation: 1 Hz
stimulation, 900 pulses; Kemp and Bashir, 2001; Massey et al.,
2004; Massey and Bashir, 2007). Indeed, low frequency stimula-
tion was unable to induce long-term depression in the wild-type
mice (97  2%, n = 6; Fig. 5A) but interestingly long-term depres-
sion was induced in tgCRND8 mice (83  3%, n = 6; Fig. 5B),
indicative of aberrant, more sensitive induction mechanisms of
NMDAR long-term depression in these mice. Memantine treat-
ment blocked the increased long-term depression in the
tgCRND8 mice (97  4%, n = 5; Fig. 5C). The parallel, normal-
izing actions of memantine on object recognition and perirhinal
NMDA receptor-long-term depression in tgCRND8 mice strongly
support the idea that false recognition and aberrant long-term
depression in perirhinal cortex may be related, although causality
cannot be assumed.
Discussion
The general aim of the present study was to attempt to shed light
on the recognition memory impairments present in Alzheimer’s
disease and in preclinical models of Alzheimer’s disease. A major
finding was that tgCRND8 mice, which model amyloid pathology
in Alzheimer’s disease, are susceptible to false recognition. That is,
these animals did not forget that they had encountered an object
before, but instead falsely treated novel objects as if they had
encountered them in the past, a pattern consistent with that
seen in human patients with Alzheimer’s disease and mild cogni-
tive impairment (Budson et al., 2003; Hildebrandt et al., 2009;
Plancher et al., 2009), and with other amnestic perturbations in
experimental animal models (Burke et al., 2010; McTighe et al.,
2010).
To test our hypothesis that the false recognition effect was due
to enhanced encoding of interfering information, we examined
performance of the mice under conditions of sensory restriction
during the delay (retention) interval. This treatment abolished the
false recognition effect. Importantly, this treatment was effective
when applied after the study phase, which suggests that
Alzheimer’s disease-typical amyloid b pathology does not prevent
the encoding of salient novel objects (because recognition memory
under sensory restriction conditions was preserved), but instead
increases susceptibility to interference. Internal controls, such as
the normal behaviour of tgCRND8 mice on repeated object
trials, indicate that these results are not due to gross changes in
perceptual ability or exploration of objects. In addition, although
tgCRND8 mice treated novel objects as familiar when followed by
a study object presented 1 h earlier, they showed normal novel
object exploration during the study phase (see further discussion
below). This finding shows that tgCRND8 mice do not have any
difficulty judging novelty per se. Instead, they appear to confuse
the memory of the study object with the novel object, resulting in
false recognition.
The pattern of false recognition and rescue with sensory restric-
tion is similar to that observed with rats with lesions of the
perirhinal cortex (McTighe et al., 2010; see also false recognition
in ageing rats; Burke et al., 2010; cf. Albasser et al., 2011; how-
ever, these authors did not observe any impairment using a
decoupled procedure following perirhinal lesions at a very
short delay). Like tgCRND8 mice, perirhinal cortex-lesioned rats
also falsely recognized novel objects, and false recognition could
be prevented by sensory restriction after the study phase
(McTighe et al., 2010). We previously concluded that in order
to judge familiarity, animals with perirhinal cortex lesions cannot
use the complex conjunctive representations housed within this
region, and instead must rely on more basic, less complex visual
features encoded in areas upstream of perirhinal cortex. Therefore,
basic visual features common to many complex visual stimuli,
which would be encountered during the delay, may provide a
false signal of familiarity for the novel object (thus we have
referred to such interference as ‘feature ambiguity’; for a more
detailed account of this proposed mechanism, see Cowell et al.,
2006; McTighe et al., 2010). The clear parallel with the findings
described here suggests that dysfunctional perirhinal cortex or
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related structures may be responsible for false recognition in
tgCRND8 mice, consistent with the observation that the perirhinal
cortex of the tgCRND8 mouse contains amyloid deposits at 2–3
months of age.
It might at first seem that the differential treatment of novel
objects by tgCRND8 mice in the test phase and the study phase is
inconsistent: if the mechanism is increased interference as we
suggest, then why is there not a similar amount of interference
present prior to presentation of the study object, leading to
tgCRND8 mice (and rats with perirhinal cortex lesions) treating
those objects as familiar? The answer, we think, is that a signifi-
cant degree of interference—or what we have previously termed
‘feature ambiguity’ (Bussey and Saksida, 2002; Saksida and
Bussey, 2011)—during the test phase comes from the trace of
the study object presented 1 h before, which is of course not
present prior to the study phase. In the case of perirhinal
cortex lesions, which yield a pattern of false recognition identical
to that in the tgCRND8 mice (McTighe et al., 2010), if the
studied and novel test objects are made more similar by sharing
more features, the resulting feature ambiguity is sufficient to
cause profound impairments even at short delays with little or
no incidental inter-delay interference. When the objects are dis-
similar, however, the degree of interference between shared fea-
tures is not sufficient to cause impairment (Eacott et al., 1994;
Bartko et al., 2007a). In this experiment, the studied and novel
test objects were relatively dissimilar, and so the prediction is that
the nature of the objects alone will not be enough to generate
an effect. However, when incidental interference caused by sti-
muli present during the delay is added, the interference is suffi-
cient to produce false recognition. Support for this interpretation
is shown by the finding that when that interference is removed
via sensory restriction, the effect is abolished (McTighe et al.,
2010).
It is worth noting that an additional mechanism may also be at
play that could exaggerate the interference during the test phase,
which is preceded by object presentation, compared with the
study phase, which is not preceded by object presentation.
After being handled, placed in the apparatus and presented
with an object, the animal is likely to be far more aroused
than when undisturbed in the home cage prior to the presenta-
tion of the study object. This arousal could lead to increased
encoding of interfering information. Indeed, there is empirical
evidence to support this idea. Winters et al. (2006) found that
infusions of the cholinergic antagonist scopolamine into perirhinal
cortex during the delay period improved object recognition in rats
(performance following vehicle infusion was relatively poor). The
interpretation was that the activity accompanying vehicle infusion
caused arousal, leading to increased encoding of interfering in-
formation during the delay. Infusion of scopolamine appeared to
have blocked this deleterious encoding, an idea supported by the
finding that scopolamine infusion prior to the encoding of
the sample impaired subsequent object recognition, and that
the interference caused by the interpolation during the delay of
a perceptually similar object (Bartko et al., 2010) could be abol-
ished by pre-interference infusions of scopolamine (Winters et al.,
2007). This interpretation was tested by assessing rats under
identical conditions but without the putatively arousing vehicle
infusion. Performance under this condition increased to the
same level as that following scopolamine infusion. Thus, there
are several reasons to expect the false recognition effect to be
reflected in decreased exploration of a novel object during the
test phase in this paradigm, but not necessarily during the sample
phase.
Figure 5 Memantine prevents long-term depression in
tgCRND8 mice. (A) Low frequency stimulation did not induce
long-term depression in wild-type mice (n = 6). (B) Low fre-
quency stimulation induced long-term depression in tgCRND8
mice (n = 6). (C) Treatment with memantine prevented the
induction of long-term depression in tgCRND8 mice (n = 5).
fEPSP = field excitatory postsynaptic potential.
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Electrophysiological data
The precise amyloid b-related mechanisms leading to cognitive
dysfunction are still unknown, but rodent models of Alzheimer’s
disease typical amyloid b pathology show aberrant plasticity mech-
anisms (Walsh et al., 2002; Hsieh et al., 2006; Shankar et al.,
2008; Li et al., 2009; Jo et al., 2011). Long-term depression of
synaptic transmission is thought to be a principle mechanism
underlying recognition memory (Cho et al., 2000; Massey and
Bashir, 2007; Griffiths et al., 2008), and amyloid b increases
NMDA receptor-dependent long-term depression (Kim et al.,
2001; Cheng et al., 2009). Furthermore, similar to sensory restric-
tion, memantine administration rescued the false recognition effect
in the tgCRND8 mice. Thus, we hypothesized that aberrant
NMDA receptor-dependent long-term depression in these mice
may have led to the aberrant encoding of interfering object infor-
mation (see Discussion section above) leading to false recognition
effects. Indeed, we found that NMDA receptor-dependent
long-term depression was increased in these mice, and that mem-
antine treatment blocked this increase. To summarize, the data
allow us to infer causal relationships between (i) the alterations
in these mice and false recognition; (ii) memantine (and sensory
restriction) treatment and the amelioration of false recognition; (iii)
the alterations in these mice and aberrant long-term depression;
and (iv) memantine and the amelioration of aberrant long-term
depression. In addition, we hypothesize a causal relationship be-
tween altered long-term depression and false memory. It should
be noted, however, that such a causal relationship cannot be
demonstrated; we offer this idea as a hypothesis only, which
will require further examination.
We have made reference to perirhinal cortex lesions, which yield
a false recognition effect identical to that seen in the tgCRND8
mice, and which can also be rescued by sensory restriction
(McTighe et al., 2010). However, tgCRND8 mice are not like
perirhinal-lesioned animals in the sense that they do not show a
high degree of neuronal loss and instead show a more global
pattern of amyloid b pathology (Chishti et al., 2001; Kobayashi
et al., 2005; Adalbert et al., 2009). On the present genetic back-
ground, diffuse and dense core amyloid deposits and dystrophic
neurites are detected as early as 2 months in the cortex and
hippocampus, and affect most brain regions, including the cere-
bellum and brainstem by 8–9 months (Chishti et al., 2001;
Kobayashi et al., 2005; Adalbert et al., 2009). Hence, it might
seem surprising that such a global insult has cognitive effects
that closely match those seen after very selective perirhinal
cortex lesions in rats. It may be, as suggested above, that the
effects observed in the CRND8 mice are due to pathology in
perirhinal cortex. However, perirhinal cortex is not the only struc-
ture implicated in object recognition; other regions implicated in
object recognition include the thalamus, and area TE (Ho et al.,
2011), and so the possibility remains that other affected structures
are contributing to these effects.
In both the case of perirhinal cortex lesions and the tgCRND8
mouse, the evidence suggests that false recognition is caused by
increased susceptibility to interference. However, in the case of
perirhinal damage, the interpretation is that animals have lost a
high-level object representation that protects memory from
interference from lower level representations (Bussey and
Saksida, 2002; McTighe et al., 2010; Saksida and Bussey,
2010). In the case of the tgCRND8 mouse, our hypothesis is
that the baseline level of interference is increased due to
enhanced NMDA receptor-dependent plasticity and perhaps
long-term depression in particular. On this account, the aberrant
encoding of interfering information due to aberrant plasticity
throughout regions that code object-related information (e.g.
perirhinal cortex and other structures such area TE, Ho et al.,
2011; area V2, Lopez-Aranda et al., 2009) may be sufficient to
cause interference leading to false recognition. It is also possible,
of course, that in the tgCRND8 mouse, both perirhinal (or
other) dysfunction and aberrant encoding of more distributed
object representations could come into play, perhaps in an addi-
tive manner.
Our findings that pathologically raised amyloid b levels lead to
object recognition deficits are in agreement with previous reports
of such impairments in tgCRND8 (Francis et al., 2012; Greco
et al., 2010) and similar common mouse models of amyloid
b pathology, such as Tg2576 and PDAPP mice (Dodart et al.,
1999, 2002a, b; Mouri et al., 2007; Taglialaleta et al., 2009;
Yuede et al., 2009). However, other studies have failed to see
object recognition deficits in Tg2576 and PDAPP mice (Chen
et al., 2000; Hale and Good, 2005). Thus, it appears that the
precise nature of the object recognition paradigm, the type of
amyloid precursor protein mutation and promoter, or the back-
ground mouse strain can have an influence on the degree of rec-
ognition memory impairment (Dodart et al., 2002a; Kobayashi
et al., 2005; Dere et al., 2007). It is conceivable that the ‘decou-
pling’ procedure used in the present study, which allows an as-
sessment of false recognition not possible with forced-choice
methodology (McTighe et al., 2010), is more sensitive to detecting
impairments than standard rodent object recognition procedures.
Relevance to Alzheimer’s disease in
humans
It is often argued that data from mouse models may not directly
translate to humans. However, initial evidence suggests that amyl-
oid b may have a similar effect in patients with Alzheimer’s disease
to that shown here in mice. False recognition has been demon-
strated a number of times in patients with Alzheimer’s disease
(Hart et al., 1985; Budson et al., 2000; Gold et al., 2007;
Plancher et al., 2009; Abe et al., 2011) and the degree of false
recognition appears to correlate with amyloid b levels in the CSF
(Hildebrandt et al., 2009). More specifically, Abe et al. (2011)
have recently shown that patients with Alzheimer’s disease show
false recognition of pictorial stimuli, especially when the studied
and target pictures are similar to each other [it is worth noting the
similarity between this effect and the findings of Bartko et al.
(2007a) discussed above]. Interestingly, repeated presentation of
a perceptually similar studied picture, which would be expected to
strengthen the representation of that stimulus, exacerbates the
effect, a finding consistent with our suggestion that amyloid b
increases the confusion of the study object with the test object.
Perhaps even more strikingly, a period in a dark quiet room, i.e.
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sensory restriction, enhanced recognition in participants with mild
cognitive impairment, a prodromal stage of Alzheimer’s disease
(Della Sala et al., 2005). Although that study could not distinguish
between misses (memory loss) and false alarms (false recognition),
it certainly provides an indication that susceptibility to interference
may be a critical component of the memory disruption seen in
Alzheimer’s disease, paralleling our results in mice. However,
such parallels, while encouraging, need to be considered with cau-
tion. False recognition in these patients may occur via different, or
additional, mechanisms to those underlying false recognition in
Alzheimer’s disease mice; for example, false recognition may
occur in humans due to a compensatory shift in bias leading to
false alarms (Werheid et al., 2011). Furthermore, confabulation
can occur particularly when prefrontal pathology is present
(Tallberg and Almkvist, 2001; Cooper et al., 2006; Attali et al.,
2009). Finally, we are modelling recognition using a paradigm that
some believe taps mostly ‘familiarity’ based, as opposed to
context-dependent ‘recollection’ based recognition memory
(Aggleton and Brown, 1999). To the extent that this idea is cor-
rect, our finding may be more relevant to the former. With further
experimentation taking these various factors into account, an
understanding of the phenomenon of false memory in
Alzheimer’s disease will become more complete.
Memantine is one of only a handful of compounds (and the
only non-cholinesterase inhibitor) approved for the treatment of
Alzheimer’s disease. In our experiments, memantine not only res-
cued the false recognition effect but also normalized the aberrant
long-term depression that we hypothesize might be part of the
mechanism underlying that effect. Recently, however, the use of
memantine as a treatment for mild Alzheimer’s disease and
mild cognitive impairment has been criticized (Schneider et al.,
2011), in part, because memantine treatment does not lead to
broad improvements in cognition in Alzheimer’s disease.
However, no study has yet investigated the effect of memantine
on false recognition in Alzheimer’s disease. The encouraging par-
allels between the animal and clinical studies may be an indica-
tion that the specific phenomenon of false recognition could be
capitalized upon (Budson et al., 2002), to provide a novel and
perhaps more sensitive paradigm for the assessment of potential
therapies to treat the mnemonic dysfunction characteristic of this
disease.
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